NRC HEALTH

For the period ended Mar 31, 2025. Filed May 9, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 9, 2025

NRC$26.85+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Shareholders’ Equity

(In thousands except share and per share amounts, unaudited)

	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Treasury Stock	Total
Balances at December 31, 2024	$31	$180,249	$(17,064)	$(131,932)	$31,284
Purchase of 307,709 shares treasury stock	-	-	-	(4,967)	(4,967)
Issuance of 10,014 shares of common stock for the exercise of stock options	-	132	-	-	132
Non-cash stock compensation expense	-	171	-	-	171
Dividends declared of $0.12 per share of common stock	-	-	(2,735)	-	(2,735)
Net income	-	-	5,787	-	5,787
Balances at March 31, 2025	$31	$180,552	$(14,012)	$(136,899)	$29,672

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’** EQUITY**

(In thousands except share and per share amounts, unaudited)

	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Treasury Stock	Total
Balances at December 31, 2023	$31	$178,213	$(30,530)	$(98,759)	$48,955
Purchase of 417,855 shares treasury stock	-	-	-	(17,220)	(17,220)
Issuance of 75,283 shares of common stock for the exercise of stock options	-	1,752	-	-	1,752
Non-cash stock compensation expense	-	(36)	-	-	(36)
Dividends declared of $0.12 per share of common stock	-	-	(2,865)	-	(2,865)
Net income	-	-	6,359	-	6,359
Balances at March 31, 2024	$31	$179,929	$(27,036)	$(115,979)	$36,945

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.